Search

Suven Life Sciences

Sector: Healthcare | Industry: Drugs & Pharma
R 250.65 -2.75  | -1.09% 32.94% 22.06 3,189.70
NSE Price: May 22, 15:57 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE May 22, 15:57 250.65 -2.75 -1.09% 253.40 253.40 130,361 249.10 - 255.15
BSE May 22, 2019 250.60 -2.50 -0.99% 252.85 253.10 25,451 250.00 - 255.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 342,874 P/B: 3.36 NSE Code: SUVEN
52-Week Range: R 182.70 - 337.80 Dividend Yield: 0.60% BSE Code: 530239
TTM EPS: R 11.36 Book Value: R 74.53 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Procter & Gamble Health (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Suven Life Sciences 10.23 -5.88 6.50 32.77 6.47 21.69 28.27
S&P BSE Small Cap -2.29 -2.94 6.30 -15.76 9.42 9.90 10.05
S&P BSE Healthcare -4.55 -7.11 -2.18 3.59 -4.53 5.71 14.67
Company's return has been calculated on basis of BSE's price.
As on May 22, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 15.04 6.28 19.38
Net Profit 28.31 13.36 38.72
EPS 28.31 13.36 36.36
Book Value 18.48 16.06 38.79
Average
Operating Margin 40.97 35.05 36.18
Net Margin 24.43 21.86 22.84
Return on Networth 19.83 18.35 30.09
Return on Investment 27.69 22.94 33.52
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 44.12 -21.16 -39.63
Operating Profit 33.40 -24.37 -58.83
Net Profit 40.11 -27.07 -59.63
EPS 40.11 -27.07 -59.63
TTM
Revenue -5.26 5.45 -0.21
Operating Profit -5.28 14.54 -6.64
Net Profit -6.08 6.33 -8.73
EPS -6.08 6.33 -8.73
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Suven Life Sciences 3,189.70 623.93 144.60 22.12 17.25 3.36 22.06
Astrazeneca Pharma India 5,504.13 688.72 47.84 6.82 11.12 18.81 115.06
Procter & Gamble Health 7,306.13 881.86 856.69 13.95 13.44 4.62 57.02
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Mar 30, 2016 Jasti Property And Equity Holdings Pvt Ltd  Buy Market 550,000 195.00 1,072.50
Sep 02, 2015 Jasti Property And Equity Holdings Pvt Ltd  Buy Market 162,424 215.25 349.62
Mar 12, 2015 Jasti Property And Equity Holding Pvt Ltd  Buy Market 75,652,576 261.05 197,491.05
Dec 22, 2014 Sudha Rani Jasti  Sell Gift 20,999,000 215.45 45,242.35
Dec 19, 2014 Kalyani Jasti  Sell Gift 10,549,000 211.95 22,358.61
Fund Houses invested in the stock
Fund Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Aditya Birla Sun Life Mutual Fund 1.340 1.325 0.757 0.835 -
L&T Mutual Fund 0.308 0.308 0.455 - -
Indiabulls Mutual Fund NA 0.056 0.056 0.050 0.062
DHFL Pramerica Mutual Fund NA 0.031 0.031 - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Suven Life Sciences Ltd.

Address: 8-2-334, S D E Serene Chambers, 6th Floor, Road No 5, Avenue 7, Banjara Hills, Hyderabad, Telangana - 500034 | Phone: +91-40- 23541142 23543311 32921695 32921696 | Fax: +91-40- 23541152

Email: [email protected]

Website: www.suven.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
10.60
Piotroski F-Score
8
Modified C-Score
3
5-Years Price to Earnings
22.28
5-Years Price to Book
3.40
Earnings Yield
EBIT / Enterprise value
7.36%
PEG
Price / Earnings to growth ratio
5.97
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,207.85 -0.12%
Dishman Carbogen Amcis R226.00 +2.91%
FDC R184.30 +1.77%
Granules India R106.65 -1.34%
Laurus Labs R375.75 +1.12%
Procter & Gamble Health R4,403.75 +2.17%
Shilpa Medicare R381.55 +1.37%
Strides Pharma Science R414.25 +0.61%
Sun Pharma Adv. Research R146.05 +0.55%
Wockhardt R394.30 +2.74%
As on May 22, 15:59